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Abstract
Purpose: This article explains the symptoms of late life depression (LLD) and
discusses evidence‐informed actions that nurses can implement to provide older
adults with the help they need.
Conclusions: Recognizing and addressing depression in older adults can enhance
quality of life.
Practice Implications: People with LLD may not appear sad or express feelings of
depression. Instead, they demonstrate loss of interest, frailty, cognitive impairment,
suicidal ideation, unexplained somatic complaints, and loneliness. Documenting
symptoms, screening, and assessing suicidal ideation are essential. Positive outcomes
are associated with antidepressant medications, cognitive behavioral therapy,
electroconvulsive therapy, neuromodulation therapies, and exercise.
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1 | INTRODUCTION
Late life depression (LLD) is the occurrence of a major depressive
disorder in adults aged 60 years or older.1 When symptoms that do
not meet major depressive disorder criteria are also considered,
subsyndromal depressive disorders and clinically significant symp-
toms of depression in later life are estimated to affect between 0.9%
and 49.0% of adults aged 65 years or older.2–4 As many as 17% of
adults over 75; 25% of adults over 85; and 49% of adults over 90 are
affected by at least some symptoms of depression.2,5
LLD is associated with cognitive impairment, increased
morbidity and mortality from co‐occurring medical illness, in-
creased death by suicide as well as increased health care
utilization and cost.1,3,6 Depression in older adults is often
undetected or inadequately treated.7–13 Existing literature has
focused on providing physicians with information related to
diagnosing and treating LLD. However, nurses in a variety of
practice areas also encounter many older adults who are
struggling to cope with symptoms of depression. Psychiatric and
mental health nurses are well positioned to provide these nurse
peers with a deeper understanding of the complexities of the
condition. When nurses recognize LLD and implement evidence‐
informed care, they are better able to support the older adults in
their care toward an improved quality of life. This article presents
an explanation of LLD and suggests nursing actions that can help.
2 | TOWARD AN EXPLANATION OF LLD
People experience depression later in their lives in different ways
and for a variety of different reasons. Explanations of LLD are seldom
straightforward. LLD is generally explained as depression that occurs
after the age of 60 years, although onset and definition of cutoff may
vary.14 Presentations of LLD can include reoccurrence of a previous
depression, termed early onset depression; a mood disorder
secondary to a general medical condition; a depressed mood
secondary to a substance or medication use (including polyphar-
macy); or as a new‐onset depression, later in life, termed late‐onset
depression (LOD).5 As many as half of the cases of LLD are late onset
and are occurring among people who have not previously experi-
enced clinically significant symptoms of depression.15 In this article,
the term LLD will refer to LOD. Unless otherwise specified, the
information presented can be considered relevant to the care of
older people experiencing any form of depression.
Both the diagnosis of major depressive disorder (MDD) and the
presence of subsyndromal or clinically significant depressive
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symptoms are associated with LLD.15 According to the Diagnostic and
Statistical Manual of Mental Disorders, 5th edition (DSM‐5),16 to
receive a diagnosis of MDD, an individual must exhibit symptoms of
depressed mood and/or loss of interest plus four or more associated
symptoms, including changes in appetite, sleep disturbance, psycho-
motor agitation or retardation, fatigue, inappropriate guilt or feelings
of worthlessness, poor concentration or indecisiveness, and recur-
rent thoughts of death or suicidal ideation. Symptoms must be
present nearly every day for at least two weeks and cause clinically
significant distress or functional impairment.16
However, in older adults, the two core symptoms of MDD,
depressed mood (sadness or dysphoria) and loss of interest in
activities once found pleasurable (anhedonia) can differ from those
seen in younger people.17 The affective symptom of a “depressed
mood” can actually be absent in some older adults who are suffering
from depression. Rather, a lack of sadness or dysphoria, known as
depression without sadness, where mood does not appear sad is
common.18–20 Similarly, rather than clear indications of sadness,
symptoms like lack of vigor, apathy, and withdrawal, known as
“depletion syndrome” are apparent.19
In contrast, the second MDD core symptom of “loss of interest” is
usually pronounced in LLD.17 Clinicians, family members, and older
adults themselves may inadvertently view anhedonia more as a part
of normal aging than as a critical indicator of depression.9 It can
inaccurately be perceived as an understandable reaction to limita-
tions imposed by medical conditions; retirement; death of a partner;
decreasing social contacts; and lifestyle changes, such as moving to a
care facility.10
Further, the additional MDD symptoms of changes in appetite,
sleep disturbance, psychomotor agitation or retardation, fatigue,
inappropriate guilt or feelings of worthlessness, poor concentration
or indecisiveness, and recurrent thoughts of death or suicidal
ideation can be overlooked in LDD. Loss of appetite and weight loss,
a common and important symptom of LLD, is also associated with
cognitive deficits21 and can predict an increased likelihood of
developing dementia.22 Sleep disturbances, particularly early morning
awakenings, are present in most cases of LLD and are predictive of a
poor prognosis and future depressive episodes.3,23
Psychomotor retardation more so than psychomotor agitation is
common in LLD.5 Although some slowing is not unexpected in normal
aging, psychomotor retardation, such as disturbances in speech, facial
expression, fine motor behavior, and gross locomotor activity
(especially a decreased walking speed) are more apparent in people
with LLD.24 Fatigue is often experienced as a physical tiring and lack
of energy rather than as a mental fatigue.25 It is important to note
that symptoms of frailty (including loss of interest, weight loss,
psychomotor slowing, and physical tiring) overlap with symptoms of
LLD and are frequently associated with comorbid medical con-
cerns.25
Inappropriate guilt or feelings of worthlessness are less frequent
in older adults than in young people.20,26 By contrast, there is often
actual impairment in peoples’ ability to concentrate and make
decisions.20 Further, compounding any assessment of how poor
concentration and indecisiveness might be linked to depression is the
question of whether medical conditions are causing disturbances in
thinking and slowing information processing abilities.6 In LLD, the
depressive symptom of “poor concentration” could be manifested
more as memory loss or cognitive impairment with executive
dysfunction (a clinical expression of frontostriatal abnormalities
where the brain is less able to control cognitive processes, such as
carrying out tasks).27 The cognitive impairments in LLD mimic
symptoms of dementia.27
This cognitive impairment also makes people with LLD at high
risk of death by suicide.28 Symptoms of recurrent thoughts of death
or suicidal ideation in LLD are especially concerning. Older adults can
act on their suicidal ideation with more serious intent, less warning,
and more lethality than younger populations.29 Signs that indicate
impending suicide include feelings of hopelessness or lack of purpose,
feeling trapped, talking about death, preparing for suicide, social
withdrawal, increased substance use, and reckless behavior.6 Factors
believed to provide some protection against acting on suicidal
thoughts include social connectedness, spirituality, religious beliefs,
and cultural attitudes against suicide.6
For older adults, particularly those living with physical illnesses,
increasing somatic complaints more so than typical symptoms of MDD
are highly suggestive of LLD.30,31 Persistent complaints of pain,
headache, fatigue, insomnia, gastrointestinal distress; unexplained
delayed recoveries after surgery; and failure to thrive in institutional
settings can be linked to depression.31 For people with cerebrovas-
cular disease, any microdamage occurring in the small vessels
compromises the ability of the frontal‐subcortical circuits to regulate
mood, resulting in a depression known as vascular or subcortical
ischemic depression.32,33 Higher rates of LLD occur in people living
with heart disease, diabetes, asthma, and arthritis.12 While it is
understandable that people will experience distress caused by their
physical illnesses, it is important to emphasize that unexplained
somatic complaints are indicative of LLD.
Finally, people experiencing loneliness, or feeling as though they
do not belong, are susceptible to LLD.34–36 Studies indicate that
between 5% and 10% of people between the ages of 60 and 80; and
between 40% and 50% of people over 80 reported feeling lonely
frequently.37 Those at greatest risk of experiencing loneliness are
women, particularly those who are older; and people who are without
partners, are financially insecure and are physically unwell.37 As
many as 87% of older adults with depressive symptoms reported co‐
occurring feelings of loneliness.36 Loneliness has been found to
exacerbate depressive symptoms, decrease quality of life, and leave
older adults feeling as though they have no control over their
situation.36
In his seminal commentary on depression in later life, Dan Blazer
urged clinicians not to limit their assessment of LLD to diagnostic
categories of depression, but rather to include depressive symptoms
that do not fully meet the criteria but nonetheless cause significant
distress.20 As the preceding discussion explained, older adults with
symptoms of depression without sadness, lack of vigor, apathy and
withdrawal, loss of interest, loss of appetite, early morning awakenings,
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decreased walking speed, physical tiring, frailty, memory loss or
cognitive impairment with executive dysfunction, suicidal ideation,
somatic complaints, and loneliness could be suffering from LDD.
Recognizing and addressing these symptoms can decrease depression
and functional impairment and enhance quality of life for older
adults.38 Next, actions that nurses can implement when they encounter
the many older adults who are struggling with depression are
suggested.
3 | PRACTICE IMPLICATIONS: ACTIONS
THAT CAN HELP
3.1 | Document symptoms of LLD
Recognizing and documenting the aforementioned symptoms of LLD
is a critical first step in helping people receive treatment for
depression. Knowing that depressed older adults are more likely to
present with loss of interest and unexplained somatic complaints
than with a sad mood or self‐identified complaints of depression,
clinicians must intentionally inquire about LLD and maintain ongoing
documentation. Seeking out information about any changes in
lifestyle, social withdrawal, and feelings of loneliness from family
members should also be included. Typical open ended interview
questions that assess history, mental status, and level of cognitive
and functional capacities should be followed by more directed
questions specific to LLD.6
3.2 | Screen with the Patient Health
Questionaire‐9
Given the prevalence, impact and difficulties inherent in recognizing
LLD, screening instruments can supplement interview findings and
provide the objective data needed to indicate the risk or presence of
depression in older adults.39 The 9‐item Patient Health Question-
naire (PHQ‐9), developed by Kroenke et al.40 provides reliable, valid
detection of depression in LLD.6,10,38,39 The PHQ‐9 is self‐adminis-
tered, requires about 5minutes to complete, is easily scored and
interpreted, and is available for free.40 The short questionnaire
incorporates DSM‐5 depression diagnostic criteria, as well as
clinically significant depressive symptoms; rates the frequency of
the symptoms and factors these into the scoring severity index;
screens for suicidal ideation; and assigns weight to the depressive
symptoms that impact how people function.40 The PHQ‐9 can be
administered in a variety of settings both as an initial screening
instrument and to follow up and evaluate interventions.10,38
3.3 | Assess suicide risk
As with any depressive illness, suicidal ideation means that protective
factors must be assessed in people who may be experiencing LLD.
Suicidal ideation can range from thinking passively about death and
wishing to die, to active thoughts of self‐harm, plans, and an intention
to die.6 In older adults, means can include but are not limited to,
hanging, firearms, poisoning, and hoarding medications.6 Posing the
question: “What stops you?” opens the door for people to express
protective factors that are unique to their situation. Clearly, ongoing
assessment, documentation, and immediate reporting of suicidal
ideation must be implemented when LLD is or could be present.
3.4 | Pharmacological treatment
Selective serotonin reuptake inhibitors (SSRIs) are the most common
first‐line treatment for LLD.1,41 The SSRI‐Sertraline (Zoloft), has a
favorable side‐effect profile and can be taken by people with a
history of cognitive impairment and stroke.41 When SSRIs are
contraindicated, alternative classes of antidepressants, such as
Mirtazapine (Remeron), demonstrate good efficacy in older adults.41
The side effects of Mirtazapine, which include sedation and weight
gain, can have therapeutic benefit to the difficulty in sleeping and
loss of appetite so commonly experienced in LLD. Tricyclic
antidepressants, in particular, Nortriptyline (Allegron, Aventyl), can
also be effective in older adults who do not have cardiac conditions
or cognitive impairment.41
Antidepressant medications are usually trialed for approximately
6 weeks; should not be withdrawn abruptly and can be expected to
be taken for at least 2 years.41 However, it is important to note that
as many as one‐third of older adults will not respond to
antidepressant treatment; relapse rates for those who do respond
are high; and the approach is less efficacious than for younger
people.13,42
3.5 | Psychological treatment
Psychological treatments, particularly when implemented in combina-
tion with pharmacological treatments have demonstrated moderate
efficacy for some older adults.31,42,43 Cognitive behavioral therapy
(CBT), problem‐solving therapy (PST), interpersonal therapy (IPT), and
reminiscence and life review therapy (RLRT) have been successfully
implemented.43,44 In CBT, people identify and challenge distorted
thinking; in PST, people identify problems, brainstorm solutions,
implement a solution, and then evaluate its effectiveness; in IPT, people
explore feelings and ways to change behavior in relation to
interpersonal relationships, including grief and role transitions; and in
RLRT people review positive life events to enhance wellbeing.43
Although therapies such as CBT, PST, and IPT are implemented
by trained therapists, adaptions of RLRT and approaches to
celebrating positive life events, both past and present, can readily
be adapted in settings where nurses provide support to older adults.
Similarly, behavioral activation (BA) therapy, which seeks to create a
personal environment of positive reinforcement by increasing
functional and pleasurable behavior, and by decreasing avoidant
and depressed behavior, uses less complex protocols, and has
successfully been implemented by mental health nurses.45 Many
older adults, especially those who are over 75 and are experiencing
depression for the first time, prefer not to talk about their depression
and do not view pharmacological and psychological treatments as
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likely to be helpful.11 Therefore, exploring people’s own ideas about
the depression they are experiencing and the solutions they believe
are valuable is foundational to any treatment approach.
3.6 | Electroconvulsive therapy
Electroconvulsive therapy (ECT) can also be effective in treating LLD.7
People who will benefit most from ECT are those with depression that
is resistant to other treatments and for those at risk of serious harm
because of psychotic depression, suicidal ideation, or severe malnutri-
tion.46 Although cardiovascular and cognitive side effects can occur with
older adults, deleterious effects of ECT in LLD are usually limited and
transient, with better cognitive outcomes with unilateral ECT.47
In one study, when elderly people with unipolar depression were
treated twice weekly with right unilateral ECT, their cognition,
psychomotor agitation, and psychomotor retardation improved
significantly.48 This improvement was attributed to a significant gray
matter volume increase, which was most pronounced on the side
receiving neurostimulation.48 Common side effects of ECT that
nurses must monitor include headache that usually responds to
analgesics, temporary confusion or memory impairment, and falls
immediately after treatment sessions.46
3.7 | Neuromodulation therapies
Alternative neuromodulation therapies also provide neurostimula-
tion, but unlike ECT, these therapies do not require anesthetic and
have reduced side effects, making them safer for older adults with
comorbid medical conditions.49 Repetitive transcranial magnetic
stimulation (rTMS) and transcranial direct‐current stimulation (tDCS)
modulate cerebral activity using brain stimulation and are usually
implemented over a 4 to 6week period.50 In older adults with
nonpsychotic depression, rTMS is well tolerated but higher inten-
sities and greater numbers of treatments may be needed than for
younger people.50 Beyond its positive effects on mood, tDCS may
also have positive effects on cognition.50
3.8 | Physical exercise
Physical exercise programs can improve outcomes with some
symptoms of LLD. In combination with antidepressant medication,
exercise programs for older adults that included brief intervals of
increased workload were found to decrease symptoms of depressed
mood and psychomotor retardation.51 Aerobic activities, which
stimulate and sustain heart and breathing rates, improved cognition
and reduced disability in depressed older adults.52
When high intensity progressive resistance training was
integrated into exercise programs, participants’ sleep quality
improved.53 Knowing that sleep disturbances are frequently
present in LLD,3,23 the value of integrating resistance training
into older adults’ physical activities becomes clear. Weekly group
exercise programs of 3 × 50 minute sessions, which included
moderate cardiovascular exercise, such as walking with waving
or clapping hands to music for a duration of 30 minutes, improved
quality of life and perceived social support.54 Exergames or
entertaining video games that combined game play with exercise
decreased subsyndromal symptoms of depression55,56 and im-
proved balance and mobility.55
In community settings, nurses can encourage older adults to
participate in seniors’ fitness activities in their area. In institutional
settings, they can advocate for the creation of fitness programs that
personalize physical exercise for patients/residents. Although med-
ical conditions can impose limitations on peoples’ mobility, engaging
in some form of daily physical exercise can make an important
difference in mood.
3.9 | Lifestyle modifications
In addition to increasing physical exercise, lifestyle modifications, such
as improving dietary patterns and addressing vitamin D deficiencies
may also exert a positive influence on some symptoms of depression.
Emerging evidence suggests that modifying dietary patterns may
reduce the risk of developing depression.57 Actions that can help
include: following the Mediterranean diet; increasing consumption of
fruits, vegetables, legumes, wholegrain cereals, nuts, and seeds;
including a high consumption of foods rich in omega‐3 polyunsaturated
fatty acids; replacing unhealthy foods with wholesome nutritious
foods; and limiting intake of processed foods, “fast” foods, commercial
bakery goods, and sweets.57
Although causal links between vitamin D deficiency and the
development of depression have not been established, studies reveal
that vitamin D deficiency accompanies late‐life depression.58 For older
adults, the skin capacity to synthesize vitamin D from sunlight can be
reduced as much as 25%, increasing the likelihood of vitamin D
deficiency.58 Those who have limited opportunities to be outdoors or to
be exposed to sunlight are particularly at risk. The 25‐hydroxy vitamin
D blood test indicates that vitamin D deficiency exists when levels are
less than 12.5 ng/mL.59 Vitamin D supplements may be helpful.
4 | CONCLUSION
Adults over 60 can experience symptoms of depression somewhat
differently than younger people. Older adults living with LLD may not
appear sad or express feelings of depression. Instead, they may
demonstrate loss of interest, frailty, cognitive impairment, suicidal
ideation, unexplained somatic complaints, and loneliness. In response,
nurses should document these symptoms, screen with the PAQ‐9 and,
importantly, assess for suicidal ideation. Antidepressant medications,
CBT, electroconvulsive therapy, neuromodulation therapies, physical
exercise, and lifestyle modifications can bring needed support and relief
to the increasing number of people burdened with LLD.
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